Cargando…
Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris
Invasive fungal infections represent an expanding threat to public health. During the past decade, a paradigm shift of candidiasis from Candida albicans to non-albicans Candida species has fundamentally increased with the advent of Candida auris. C. auris was identified in 2009 and is now recognized...
Autores principales: | Billamboz, Muriel, Fatima, Zeeshan, Hameed, Saif, Jawhara, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003017/ https://www.ncbi.nlm.nih.gov/pubmed/33803604 http://dx.doi.org/10.3390/microorganisms9030634 |
Ejemplares similares
-
Editorial: Candida auris - understanding the new superbug
por: Banik, Sukalyani
Publicado: (2023) -
Anti-Malassezia Drug Candidates Based on Virulence Factors of Malassezia-Associated Diseases
por: Billamboz, Muriel, et al.
Publicado: (2023) -
Natural Compounds with Antifungal Properties against Candida albicans and Identification of Hinokitiol as a Promising Antifungal Drug
por: Camaioni, Louis, et al.
Publicado: (2023) -
Antifungal Properties of Hydrazine-Based Compounds against Candida albicans
por: Camaioni, Louis, et al.
Publicado: (2023) -
Small molecules for combating multidrug-resistant superbug Candida auris infections
por: Tu, Jie, et al.
Publicado: (2022)